EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17

Guillaume Dolla, Sarah Nicolas, Ligia Ramos Dos Santos, Alexandre Bourgeois, Raphaëlle Pardossi-Piquard, Franck Bihl, Christelle Zaghrini, Joana Justino, Christine Payré, Pascal Mansuelle, Christoph Garbers, Pierre Ronco und 3 weitere

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Guillaume Dolla und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre National de la Recherche Scientifique, Inserm, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, Université Côte d'Azur (…. Hauptthemen laut MEDLINE: ADAM10 Protein, ADAM17 Protein, Amyloid Precursor Protein Secretases, Membrane Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phospholipase A2 receptor 1 (PLA2R1) is a 180-kDa transmembrane protein that plays a role in inflammation and cancer and is the major autoantigen in membranous nephropathy, a rare but severe autoimmune kidney disease. A soluble form of PLA2R1 has been detected in mouse and human serum. It is likely produced by proteolytic shedding of membrane-bound PLA2R1 but the mechanism is unknown. Here, we show that human PLA2R1 is cleaved by A Disintegrin And Metalloprotease 10 (ADAM10) and ADAM17 in HEK293 cells, mouse embryonic fibroblasts, and human podocytes. By combining site-directed mutagenesis and sequencing, we determined the exact cleavage site within the extracellular juxtamembrane stalk of human PLA2R1. Orthologs and paralogs of PLA2R1 are also shed. By using pharmacological inhibitors and genetic approaches with RNA interference and knock-out cellular models, we identified a major role of ADAM10 in the constitutive shedding of PLA2R1 and a dual role of ADAM10 and ADAM17 in the stimulated shedding. We did not observe evidence for cleavage by β- or γ-secretase, suggesting that PLA2R1 may not be a substrate for regulated intramembrane proteolysis. PLA2R1 shedding occurs constitutively and can be triggered by the calcium ionophore ionomycin, the protein kinase C activator PMA, cytokines, and lipopolysaccharides, in vitro and in vivo. Altogether, our results show that PLA2R1 is a novel substrate for ADAM10 and ADAM17, producing a soluble form that is increased in inflammatory conditions and likely exerts various functions in physiological and pathophysiological conditions including inflammation, cancer, and membranous nephropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM10 ProteinADAM17 ProteinAmyloid Precursor Protein SecretasesMembrane ProteinsReceptors, Phospholipase A2HumansAnimalsMiceHEK293 CellsPodocytesProteolysisProtein DomainsIonomycin

Stichwörter der Autor:innen

ADAM10ADAM17PLA2R1inflammationmembranous nephropathymetalloproteasespodocytesheddingsoluble PLA2R1

Substanzen

ADAM10 ProteinADAM17 ProteinAmyloid Precursor Protein SecretasesADAM10 protein, humanADAM17 protein, humanMembrane ProteinsPLA2R1 protein, humanReceptors, Phospholipase A2Adam17 protein, mouseAdam10 protein, mouse

Autor:innen und Institutionen

  • Centre National de la Recherche Scientifique, Inserm, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, Université Côte d'Azur (UniCa), Valbonne, France.
  • Centre National de la Recherche Scientifique, Inserm, Institut de Pharmacologie Moléculaire et Cellulaire, Laboratoire d'Excellence DistALZ, Sophia Antipolis, Université Côte d'Azur (UniCa), Valbonne, France.
  • Plateforme de Protéomique de l'Institut de Microbiologie de la Méditerranée (IMM), Marseille Protéomique (MaP), Aix Marseille Université (AMU), Centre National de la Recherche Scientifique (CNRS) FR3479, Marseille, Fran…
  • Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
  • Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S1155, Paris, France; Sorbonne Université, Université Pierre et Marie Curie Paris 06, Paris, France.
  • Centre National de la Recherche Scientifique, Inserm, Institut de Pharmacologie Moléculaire et Cellulaire, Sophia Antipolis, Université Côte d'Azur (UniCa), Valbonne, France. Electronic address: lambeau@ipmc.cnrs.fr.

Zitieren

APA

Dolla, G., Nicolas, S., Dos Santos, L. R., Bourgeois, A., Pardossi-Piquard, R., Bihl, F., Zaghrini, C., Justino, J., Payré, C., Mansuelle, P., Garbers, C., Ronco, P., Checler, F., Lambeau, G., & Petit-Paitel, A. (2024). Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107480

Vancouver

Dolla G, Nicolas S, Dos Santos LR, Bourgeois A, Pardossi-Piquard R, Bihl F, et al. Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107480

BibTeX
@article{Dolla2024,
  author = {Dolla, Guillaume and Nicolas, Sarah and Dos Santos, Ligia Ramos and Bourgeois, Alexandre and Pardossi-Piquard, Raphaëlle and Bihl, Franck and Zaghrini, Christelle and Justino, Joana and Payré, Christine and Mansuelle, Pascal and Garbers, Christoph and Ronco, Pierre and Checler, Frédéric and Lambeau, Gérard and Petit-Paitel, Agnès},
  title = {Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107480}
}
Kostenlos starten →